Skip to main content
. 2022 Aug 22;4(8):1071–1083. doi: 10.1038/s42255-022-00617-6

Extended Data Fig. 1. Structure and pharmacokinetics of the GLP-1RA and the GLP-1RA/Tesaglitazar conjugate.

Extended Data Fig. 1

Chemical structures of the GLP-1RA (a) and the GLP-1RA/Tesaglitazar conjugate (b). Pharmacokinetic analysis of GLP-1RA and GLP-1RA/Tesaglitazar in 25–30-week-old male C57BL6/J mice (n = 4/4 mice) and 8–10-week-old male Sprague Dawley rats (n = 4/4 rats) (c). Abbreviations indicate half-life (T1/2), maximum plasma concentration (Cmax), time for maximal plasma concentration (Tmax) and area under the curve from zero to last valid measurable concentration-timepoint (AUC0-t). N/D not determinable. Data represent means ± SEM.

Source data